Clinical trial

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral…

NCT00014235 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00014235
Title Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Official title Nonmyeloablative PBSC Allografting From HLA Matched Related Donors Using Fludarabine and/or Low Dose TBI With Disease-Risk Based Immunosuppression
Lead sponsor Fred Hutchinson Cancer Center, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH National Cancer Institute (NCI)
Status Completed
Study type Interventional
Conditions Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22 and 73 more
Intervention type Drug, Other, Procedure, Radiation
Interventions fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation, allogeneic hematopoietic stem cell transplantation, cyclosporine, mycophenolate mofetil, laboratory biomarker analysis
Enrollment 160
Start date Dec 1, 2000
Primary completion Feb 1, 2005
First posted Jan 27, 2003
Last update posted Jan 21, 2020
Countries Germany, Italy, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies